|

Penpulimab Clinical Trials

2 actively recruiting trials

▼ -1 trial since July 2026

Also known as: PD-1 monoclonal antibody

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Ruijin Hospital1
  • Akeso1

Indications

  • Cancer2
  • Non-small Cell Lung Cancer Stage IIIB/IV1
  • Colorectal Adenocarcinoma1
  • Locally Advanced1
  • Head and Neck Squamous Cell Carcinoma (HNSCC)1

Other2 trials

AK129 Combination Therapy for Advanced Solid Tumors
Phase 1/2
SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.